COBAS LUMIRA
Live / Allowed — Publication / registration review complete (as of 19 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99117674
- Mark type
- Stylized text
- Filed
- 02 Apr 2025
- Published for opposition
- 07 Apr 2026
- Attorney of record
- Mona Gupta
Goods and services
- Class 005 — Pharmaceuticals: Chemical, biological and biochemical preparations for the analysis of biological samples for medical purposes; medical diagnostic assays and reagents for the analysis of biological samples for clinical or medical purposes; diagnostic reagents and preparations for medical purposes; in vitro diagnostic agents for the analysis of biological samples for medical purposes; all of the foregoing excluding active pharmaceutical ingredients, isotopes and radioisotopes
- Class 010 — Medical apparatus: Analyzers for the analysis of biological samples for medical diagnostic purposes; in vitro diagnostic devices in the nature of biosensors for the detection and analysis of medically significant analytes in biological samples for medical purposes
Owner
- Roche Diagnostics Operations, Inc., Indianapolis, IN, US
Prior registrations
Prosecution history
- 01 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 16 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Feb 2026 — ASSIGNED TO LIE
- 17 Feb 2026 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 08 Dec 2025 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 08 Dec 2025 — LETTER OF SUSPENSION E-MAILED
- 08 Dec 2025 — SUSPENSION LETTER WRITTEN
- 17 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Oct 2025 — NON-FINAL ACTION E-MAILED
- 16 Oct 2025 — NON-FINAL ACTION WRITTEN